Pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in early-stage NSCLC

被引：0
作者：
Schmid-Bindert, G.
Chemaissani, A.
Fischer, J. R.
Schuette, W.
Mazieres, J.
Vinolas, N.
Wolf, M.
Vaury, A. Thareau
Leschinger, M.
Reck, M.
机构：
[1] Univ Heidelberg, Univ Ctr Mannheim, D-6800 Mannheim, Germany
[2] Lung Clin Cologne Merheim, Cologne, Germany
[3] Klinikum Loewenstein gGmbH, Loewenstein, Germany
[4] Hosp Martha Maria, Halle Doelau, Germany
[5] Larrey Hosp, Toulouse, France
[6] Hosp Clin Barcelona, Barcelona, Spain
[7] Klinikum Kassel Med Kilin IV, Kassel, Germany
[8] Lilly France, Suresnes, France
[9] Lilly Deutschland GmbH, Bad Homburg, Germany
[10] Hosp Grosshansdorf, Grosshansdorf, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7565
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Trial on Refinement of Early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: The TREAT protocol
    Kreuter, Michael
    Vansteenkiste, Johan
    Griesinger, Frank
    Hoffmann, Hans
    Dienemann, Hendrik
    De Leyn, Paul
    Thomas, Michael
    BMC CANCER, 2007, 7 (1)
  • [32] Trial on Refinement of Early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: The TREAT protocol
    Michael Kreuter
    Johan Vansteenkiste
    Frank Griesinger
    Hans Hoffmann
    Hendrik Dienemann
    Paul De Leyn
    Michael Thomas
    BMC Cancer, 7
  • [33] Adjuvant chemotherapy with carboplatin and taxane compared with single drug carboplatin in early stage epithelial ovarian carcinoma
    Skirnisdottir, Ingiridur
    Lindborg, Katarina
    Sorbe, Bengt
    ONCOLOGY REPORTS, 2007, 18 (05) : 1249 - 1256
  • [34] Adjuvant Chemotherapy in Early-Stage Breast Cancer: What, When, and for Whom?
    Kelly, Catherine M.
    Hortobagyi, Gabriel N.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 19 (03) : 649 - +
  • [35] Factors Affecting the Completion of Adjuvant Chemotherapy in Early-Stage Breast Cancer
    Sylvia A. Reyes
    Tari A. King
    Kezhen Fei
    Rebeca Franco
    Nina A. Bickell
    Annals of Surgical Oncology, 2016, 23 : 1537 - 1542
  • [36] Optimal Adjuvant Chemotherapy Regimens for Patients With Early-Stage Breast Cancer
    Del Mastro, Lucia
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (10) : 1137 - +
  • [37] Re: Adjuvant chemotherapy in patients with early-stage ovarian cancer - Response
    Guthrie, D
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (15) : 1169 - 1170
  • [38] Optimal exposure to docetaxel in adjuvant chemotherapy for early-stage breast cancer
    Guo, Jujiang
    Lin, Weijie
    Weng, Yiyin
    Chen, Yao
    Zeng, Shaowu
    Lin, Juli
    Zheng, Xiuluan
    Li, Xiuqing
    Lin, Min
    Yu, Xuefen
    Chen, Quanyao
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (12) : 2205 - 2213
  • [39] Factors Affecting the Completion of Adjuvant Chemotherapy in Early-Stage Breast Cancer
    Reyes, Sylvia A.
    King, Tari A.
    Fei, Kezhen
    Franco, Rebeca
    Bickell, Nina A.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (05) : 1537 - 1542
  • [40] Current and future directions for adjuvant chemotherapy in early-stage breast cancer
    Ellis, P
    EJC SUPPLEMENTS, 2006, 4 (04): : 14 - 20
12345